Injecting-related injury and disease among clients of a supervised injecting facility

Drug and Alcohol Dependence

Volumn 101, Issue 1-2, 2009, Pages 132-136

  Salmon, Allison M ^a   Dwyer, Robyn ^b   Jauncey, Marianne ^a,c   van Beek, Ingrid ^c   Topp, Libby ^a,d   Maher, Lisa ^a  

^a UNIVERSITY OF NEW SOUTH WALES   (Australia)

^b MACFARLANE BURNET INSTITUTE FOR MEDICAL RESEARCH AND PUBLIC HEALTH   (Australia)

^c Sydney Medically Supervised Injecting Centre   (Australia)

^d Justice Health Centre for Health Research in Criminal Justice   (Australia)

Author keywords

Drug consumption rooms; Injecting drug use; Injecting related diseases; Injecting related injuries; Medically supervised injecting facilities; Supervised injecting facilities

Indexed keywords

DIAMORPHINE;

ADULT; ARTICLE; DEMOGRAPHY; DRUG OVERDOSE; DRUG USE; ENDOCARDITIS; FEMALE; HUMAN; INJECTION SITE DISCOMFORT; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SELF REPORT; SEPTICEMIA; SKIN INFECTION; THROMBOSIS;

ADULT; AGE OF ONSET; CROSS-SECTIONAL STUDIES; DATA COLLECTION; ETHNIC GROUPS; FEMALE; HUMANS; INCOME; INJECTIONS, INTRAVENOUS; MALE; NEEDLE SHARING; NEW SOUTH WALES; OVERDOSE; SOCIOECONOMIC FACTORS; SUBSTANCE ABUSE, INTRAVENOUS; YOUNG ADULT;

EID: 60249096517     PISSN: 03768716     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.drugalcdep.2008.12.002     Document Type: Article

References (54)

1. Black E., Stafford J., and Degenhardt L. An Overview of the 2007 IDRS: The Injecting Drug User Survey Findings (2007), National Drug and Alcohol Research Centre, University of New South Wales, Sydney
2. Centres for Disease Control and Prevention, 2001. Update: Clostridium novyi and Unexplained Illness Among Injecting-Drug-Users - Scotland, Ireland, and England, April-June 2000. Ann. Emerg. Med. 37, 107-108.
3. Contoreggi C., Rexroad V.E., and Lange W.R. Current management of infectious complications in the injecting drug user. J. Subst. Abuse Treat. 15 (1998) 95-106
4. Crossley M. Temperate pyomyositis in an injecting drug misuser. A difficult diagnosis in a difficult patient. Emerg. Med. 20 (2003) 299-300
5. Darke S., Kaye S., and Ross J. Geographical injecting locations among injecting drug users in Sydney, Australia. Addiction 96 (2001) 241-246
6. Darke S., Ross J., and Kaye S. Physical injecting sites among injecting drug users in Sydney, Australia. Drug Alcohol Depend. 62 (2001) 77-82
7. Darke S., Topp L., and Ross J. The injection of methadone and benzodiazepines among Sydney injecting drug users 1996-2000: 5-year monitoring of trends from the Illicit Drug Reporting System. Drug Alcohol Rev. 21 (2002) 27-32
8. De Irala J., Bigelow C., McCusker J., Hindin R., and Zheng L. Reliability of self-reported human immunodeficiency virus risk behaviours in a residential drug treatment population. Am. J. Epidemiol. 143 (1996) 725-732
9. Degenhardt L., Black E., Breen C., Bruno R., Kinner S., Roxburgh A., Fry C., Jenkinson R., Ward J., and Fetherston J. Trends in morphine prescriptions, illicit morphine use and associated harms among regular injecting drug users in Australia. Drug Alcohol Rev. 25 (2006) 403-412
10. Del Giudice P. Cutaneous complications of intravenous drug abuse. Br. J. Dermatol. 150 (2004) 1-10
11. Des Jarlais D.C., Paone D., Milliken J., Turner C.F., Miller H., Gribble J., Shi Q., Hagan H., and Friedman S. Audio-computer interviewing to measure risk behaviour for HIV among injecting drug users: a quasi-randomised trial. Lancet 353 (1999) 1657-1661
12. Dolan K., Kimber J., Fry C., Fitzgerald J., McDonald D., and Frautmann F. Drug consumption facilities in Europe and the establishment of supervised injecting centres in Australia. Drug Alcohol Rev. 19 (2000) 337-346
13. Drucker E. Insite: Canada's landmark safe injecting program at risk. Harm. Reduct. J. 3 (2006) 24
14. Evans J.L., Hahn J.A., Page-Shafer K., Lum P.J., Stein E.S., and Davidson P.J. Gender differences in sexual and injection risk behavior among active young injection drug users in San Francisco (the UFO Study). J. Urban Health 80 (2003) 137-146
15. Frazee B.W., Lynn J., Charlebois E.D., Lambert L., Lowery D., and Perdreau-Remington F. High prevalence of methicillin-resistant Staphylococcus aureus in Emergency Department Skin and Soft Tissue Infections. Ann. Emerg. Med. 45 (2005) 311-320
16. Gordon R.J., and Lowy F.D. Bacterial infections in drug users. N. Engl. J. Med. 353 (2005) 1945-1954
17. Greenfield L., Bigelow G.E., and Brooner R.K. Validity of intravenous drug abusers' self-reported changes in HIV high-risk drug use behaviors. Drug Alcohol Depend. 39 (1995) 91-98
18. Harris H.W., and Young D.M. Care of injecting drug users with soft tissue infections in San Francisco, California. Arch. Surg. 137 (2002) 1217-1222
19. Hedrich D. European Report on Drug Consumption Rooms (2004), European Monitoring Centre for Drugs and Drug Addiction, Lisbon
20. Hsieh Y.-H., Khalil A., Wazir S., Majmudar M., Moring-Parris D., Tenoso M., and Rothman R.E. Factors predicting differential duration of hospital stay among inner-city injection drug users with skin/soft tissue infections. Acad. Emerg. Med. 13 (2006) S143-S144
21. Irish C., Maxwell R., Dancox M., Brown P., Trotter C., Verne J., and Shaw M. Hospital admissions in drug-users for skin and soft tissue infections and vascular disorders: geographical distribution in England, April 2001 to March 2006. J. Infect. 55 (2007) 71-72
22. Jenkinson R.A., Clark N.C., Fry C.L., and Dobbin M. Buprenorphine diversion and injection in Melbourne, Australia: an emerging issue?. Addiction 100 (2005) 197-205
23. Kerr T., Wood E., Grafstein E., Ishida T., Shannon K., Lai C., Montaner J., and Tyndall M.W. High Rates of Primary Care and Emergency Department use among injection drug users in Vancouver. J. Public Health 27 (2005) 62-66
24. Kimber J., Dolan K., van Beek I., Hedrich D., and Zurhold H. Drug consumption facilities: an update since 2000. Drug Alcohol Rev. 22 (2003) 227-233
25. Kral A., Bluthenthal R., Erringer E., Lorvick J., and Edlin B. Risk factors among IDUs who give injections to or receive injections from other drug users. Addiction 94 (1999) 675-683
26. Latkin C.A., and Vlahov D. Socially desirable response tendency as a correlate of accuracy of self-reported HIV serostatus for HIV seropositive injection drug users. Addiction 93 (1998) 1191-1197
27. Lloyd-Smith E., Kerr T., Hogg R.S., Li K., Montaner J.S.G., and Wood E. Prevalence and correlates of abscesses among a cohort of injection drug users. Harm. Reduct. J. 2 (2005) 24
28. Lowy F.D., and Miller M. New methods to investigate infectious disease transmission and pathogenesis-Staphylococcus aureus disease in drug users. The Lancet (Infect. Dis.) 2 (2002) 605-612
29. Macalino G.E., Celentano D.D., Latkin C., Strathdee S.A., and Vlahov D. Risk behaviors by audio computer-assisted self-interviews among HIV-seropositive and HIV-seronegative injection drug users. AIDS Educ. Prev. 14 (2002) 367-378
30. Maher L., and Dixon D. Policing and public health: law enforcement and harm minimization in a street-level drug market. Br. J. Criminol. 39 (1999) 488-512
31. Maher L., and Salmon A. Supervised injecting facilities: how much evidence is enough?. Drug Alcohol Rev. 26 (2007) 351-353
32. McKay J.R., Rutherford M.J., Cacciola J.S., Kabasakalian-McKay R., and Alterman A.I. Gender differences in the relapse experiences of cocaine patients. J. Nerv. Ment. Dis. 184 (1996) 616-622
33. Morrison A., Elliott L., and Gruer L. Injecting-related harm and treatment-seeking behaviour among injecting drug users. Addiction 92 (1997) 1349-1352
34. Murphy E., DeVita D., Liu H., Vittinghoff E., Leung P., Ciccarone D.H., and Edlin B.R. Risk factors for skin and soft tissue abscesses among injection drug users: a case control study. Clin. Infect. Dis. 33 (2001) 35-40
35. Murphy S., and Waldorf D. Kicking down to the street doc: Shooting galleries in the San Francisco Bay Area. Contemp. Drug Probl. 28 (1991) 9-29
36. National Centre in HIV Epidemiology Clinical Research, 2007. Sydney Medically Supervised Injecting Centre Evaluation Report 4: Evaluation of Service Operation and Overdose-related Events. UNSW, Sydney.
37. O'Connell J., Kerr T., Li K., Tyndall M., Hogg R., Montaner J., and Wood E. Requiring help injecting independently predicts incident HIV infection among injection drug users. J. Acquir. Immun. Defic. Syndr. 40 (2005) 83-88
38. O'Brien S., Black E., Degenhardt L., Roxburgh A., Campbell G., de Graaff B., Fetherston J., Jenkinson R., Kinner S., Moon C., and White N. Australian Drug Trends 2006: Findings from the Illicit Drug Reporting System (IDRS) (2006), National Drug and Alcohol Research Centre, Sydney
39. Padesky C.A., and Hammen C.L. Sex differences in depressive symptom expression and help-seeking among college students. Sex Roles 7 (1981) 309-320
40. Palepu A., Tyndall M., Leon H., Muller J., O'Shaughnessy M., Schechter M., and Anis A.H. Hospital utilization and costs in a cohort of injection drug users. CMAJ 165 (2001) 415-420
41. Rhodes T. The 'risk environment': a framework for understanding and reducing drug-related harm. Int. J. Drug Policy 13 (2002) 85-94
42. Rhodes T., Briggs D., Kimber J., Jones S., and Holloway G. Crack-heroin speedball injection and its implications for vein care: qualitative study. Addiction 102 (2007) 1782-1790
43. Rhodes T., Stimson G.V., Crofts N., Ball A.L., Dehne K.L., and Khodakevich L. Drug injecting, rapid HIV spread, and the 'risk environment': implications for assessment and response. AIDS 13 (1999) 259-269
44. Rhodes T., Stoneman A., Hope V., Hunt N., Martin A., and Judd A. Groin injecting in the context of crack cocaine and homelessness: from "risk boundary" to "acceptable risk"?. Int. J. Drug Policy 17 (2006) 164-170
45. Spijkerman I.J., van Ameijden E.J., Mientjes G.H., Coutinho R.A., and van den Hoek A. Human immunodeficiency virus infection and other risk factors for skin abscesses and endocarditis among injecting drug users. J. Clin. Epidemiol. 49 (1996) 1149-1154
46. Spittal P.M., and Schechter M.T. Injection drug use and despair through the lens of gender. Can. Med. Assoc. 164 (2001) 802-803
47. Strathdee S.A., and Pollini R. A 21st century Lazarus: the role of safer injecting sites in harm reduction and recovery. Addiction 102 (2007) 848-849
48. Thom B. Sex differences in help-seeking for alcohol problems-1. The barriers to help-seeking. Br. J. Addict. 81 (1986) 777-788
49. Topp L., Iversen J., Conroy A., Salmon A., and Maher L. Prevalence and predictors of injecting-related injury and disease among clients of Australia's Needle and Syringe Programs. Aust. J. Public Health 32 (2008) 34-37
50. van Beek I. The Sydney Medically Supervised Injecting Centre: a clinical model. J. Drug Issues 33 (2003) 625-638
51. van Beek I., Dwyer R., and Malcolm A. Cocaine injecting: the sharp end of drug-related harm!. Drug Alcohol Rev. 20 (2001) 333-342
52. Vlahov D., Sullivan M., Astemborski J., and Nelson K.E. Bacterial infections and skin cleaning prior to injection among intravenous drug users. Public Health Reports 107 (1992) 595-598
53. Wood E., Tyndall M., Montaner J., and Kerr T. Summary of findings from the evaluation of a pilot medically supervised safer injecting facility. CMAJ 175 (2006) 1399-1404
54. Woodburn K.R., and Murie J.A. Vascular complications of injecting drug misuse. Br. J. Surg. 83 (1996) 1329-1334